ECSP11011190A - Anticuerpos monoclonales anti-rhd - Google Patents

Anticuerpos monoclonales anti-rhd

Info

Publication number
ECSP11011190A
ECSP11011190A EC2011011190A ECSP11011190A ECSP11011190A EC SP11011190 A ECSP11011190 A EC SP11011190A EC 2011011190 A EC2011011190 A EC 2011011190A EC SP11011190 A ECSP11011190 A EC SP11011190A EC SP11011190 A ECSP11011190 A EC SP11011190A
Authority
EC
Ecuador
Prior art keywords
monoclonal antibodies
rhd monoclonal
rhd
production
methods
Prior art date
Application number
EC2011011190A
Other languages
English (en)
Inventor
Gautam Vinod Daftary
John Kaundinya
Tomas Cinek
Original Assignee
Bharat Serums And Vaccines Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums And Vaccines Ltda filed Critical Bharat Serums And Vaccines Ltda
Publication of ECSP11011190A publication Critical patent/ECSP11011190A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Anticuerpos monoclonales anti-RhD y métodos para la producción de los mismos.
EC2011011190A 2008-12-31 2011-07-07 Anticuerpos monoclonales anti-rhd ECSP11011190A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2730MU2008 2008-12-31

Publications (1)

Publication Number Publication Date
ECSP11011190A true ECSP11011190A (es) 2011-09-30

Family

ID=42316926

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011011190A ECSP11011190A (es) 2008-12-31 2011-07-07 Anticuerpos monoclonales anti-rhd

Country Status (10)

Country Link
US (1) US8529903B2 (es)
EP (2) EP2450381B1 (es)
CN (1) CN102272160A (es)
AU (1) AU2009336567B2 (es)
CA (1) CA2746350C (es)
EA (1) EA024722B1 (es)
EC (1) ECSP11011190A (es)
ES (2) ES2692173T3 (es)
MX (1) MX2011006869A (es)
WO (1) WO2010079510A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2992104B1 (en) * 2013-05-03 2019-04-17 Fujifilm Diosynth Biotechnologies UK Limited Expression process
US20160311918A1 (en) * 2013-12-16 2016-10-27 Texas Tech University System Anti-Ron Monoclonal Antibodies as a Cytotoxic Drug Delivery System for Targeted Cancer Therapy
RU2688627C2 (ru) 2014-03-31 2019-05-22 Университетет И Тромсё - Норгес Арктиске Университет АНТИТЕЛА К HPA-1a
CA2956072A1 (en) * 2014-07-21 2016-01-28 Bloodworks Antibodies that recognize red blood cell antigens
WO2017005923A1 (en) * 2015-07-09 2017-01-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) Lentiviral vector expressing membrane-anchored or secreted antibody
CN114409791B (zh) * 2022-01-26 2023-01-24 南京医科大学 一种全人源抗人红细胞RhD全分子IgG及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610106D0 (en) 1986-04-25 1986-05-29 Central Blood Lab Authority Human igm-producing heterohybridoma
GB8722018D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
US6475787B1 (en) 1989-07-28 2002-11-05 Wyeth Method for producing monoclonal antibodies
FR2724182B1 (fr) * 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
FR2807767B1 (fr) 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d

Also Published As

Publication number Publication date
US8529903B2 (en) 2013-09-10
ES2692173T3 (es) 2018-11-30
CA2746350A1 (en) 2010-07-15
EP2370469A2 (en) 2011-10-05
EP2370469B1 (en) 2018-09-05
EA024722B1 (ru) 2016-10-31
WO2010079510A3 (en) 2010-10-07
EP2450381A1 (en) 2012-05-09
CN102272160A (zh) 2011-12-07
AU2009336567A1 (en) 2011-06-30
ES2740051T3 (es) 2020-02-05
EP2450381B1 (en) 2019-07-03
AU2009336567B2 (en) 2014-02-20
CA2746350C (en) 2018-06-12
EA201100884A1 (ru) 2012-02-28
MX2011006869A (es) 2011-07-19
US20120027769A1 (en) 2012-02-02
WO2010079510A2 (en) 2010-07-15

Similar Documents

Publication Publication Date Title
CO7151527A2 (es) Anticuerpos anti-cd79 b e inmunoconjugados
CR20140441A (es) Anticuerpos anti-lgr5 e inmunoconjugados
CO7151529A2 (es) Anticuerpos anti-cd22 e inmunoconjugados
UY32501A (es) Anticuerpo antagonista específico para el heterodímero alfa4-beta7
CR20150049A (es) Anticuerpos e inmunoconjugados anti-cd79b
CO6771458A2 (es) Conjugados de anticuerpo-fármaco
EA201390933A1 (ru) Антитела против мезотелина и иммуноконъюгаты
UY34206A (es) Anticuerpo monoclonal de interleucina-31
CL2009000632S1 (es) Estacion para fumadores.
BRPI1014474A2 (pt) anticorpos biespecíficos anti-erbb-1/anti-c-met.
CL2009001263S1 (es) Maquina de afeitar.
EA201201435A1 (ru) ГЕТЕРОДИМЕРНЫЕ АНТИТЕЛО-Fc-СОДЕРЖАЩИЕ БЕЛКИ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
CR20140212A (es) Anticuerpos anti-htra1 y métodos de uso
DK2225280T3 (da) Bivalente, bispecifikke antistoffer
BRPI0821375A2 (pt) Anticorpos biespecíficos, bivalentes
BRPI0821405A2 (pt) Anticorpos biespecíficos, bivalentes
BRPI0817273A2 (pt) Região constante de anticorpo modificada
BRPI0916915A2 (pt) anticorpos anti-il-17a/f de reatividade cruzada e biespecíficos
UY34394A (es) Polipéptidos de anticuerpos que antagonizan cd40l
BRPI0918178A2 (pt) anticorpos monoclonais para tratamento de câncer
BR112013007237A2 (pt) ''método para produzir um anticorpo anti-ig-1r''
ECSP11011190A (es) Anticuerpos monoclonales anti-rhd
BRPI0818674A2 (pt) Método para produção de anticorpos
ATE512185T1 (de) Heterobifunktionelle polyethylenglycol-reagenzien
TR201105080T2 (tr) Özet başlığı bulunamadı.